Incyte to Present at Upcoming Investor Conference
WILMINGTON, Del.--(BUSINESS WIRE)--Nov 14, 2019--
Incyte Corporation (Nasdaq:INCY) announced today that it will present at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 8:30 am (EST) in New York.
The presentation will be webcast live and can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s web site at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191114005002/en/
+1 302 498 6171
Michael Booth, DPhil
+1 302 498 5914
KEYWORD: NEW YORK DELAWARE UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Incyte Corporation
Copyright Business Wire 2019.
PUB: 11/14/2019 08:00 AM/DISC: 11/14/2019 08:01 AM